Skip to product information
1 of 1

WALA remedies GmbH

NERVUS FACIALIS GL D 12 ampoules

NERVUS FACIALIS GL D 12 ampoules

Regular price £131.55 GBP
Regular price £200.00 GBP Sale price £131.55 GBP
Sale Sold out
Taxes included.

NERVUS FACIALIS GL D 12 ampoules

Pack size:10 x 1 ml Dosage form:Ampoules

"Nervus facialis" refers to the facial nerve, a cranial nerve responsible for facial movement and sensation. While the phrase "NERVUS FACIALIS ampoules" isn't a standard medical term, it's possible it's being used to describe a type of medication or product that could be related to facial nerve health or issues. Without more context, it's difficult to say what the exact use of these ampoules would be.
Here's what's known about the facial nerve and some related uses of injectable medications:
Facial Nerve Function:
The facial nerve (cranial nerve VII) controls the muscles of facial expression, allowing for a wide range of movements and expressions. It also plays a role in sensory functions like taste and lacrimation. 
Possible Uses:
Injected medications like Voltarol Ampoules (diclofenac sodium) can be used to manage pain and inflammation. While not directly targeting the facial nerve, they could be used to address conditions that may cause facial nerve problems, such as pain or inflammation around the nerve. 
Facial Nerve Issues:
Conditions like Bell's palsy, which causes temporary facial paralysis, can affect the facial nerve. Other potential causes of facial nerve damage include infections, tumors, trauma, and certain surgical procedures. 
Therapeutic Strategies:
There are emerging therapeutic strategies for facial nerve regeneration, such as the use of DPCs (dermal progenitor cells) or BM-MSCs (bone marrow-derived mesenchymal stem cells). These substances show promise in promoting nerve regeneration and recovery. 

Nervus facialis Gl D12, liquid dilution for injection. Active ingredient: Nervus facialis bovis Gl. Indications: Registered homeopathic medicinal product of the anthroposophical therapeutic approach, therefore no therapeutic indication is specified.

For risks and side effects, read the package insert and ask your doctor or pharmacist.


PACKAGE LEAFLET: INFORMATION FOR THE USER

Nervus facialis Gl D12, liquid dilution for injection.
Active ingredient: Nervus facialis bovis Gl.

Composition:
1 ampoule contains: Nervus facialis bovis Gl Dil. D12 1 ml (HAB, Vs. 41a).

Indications:
Registered homeopathic medicinal product of the anthroposophical therapeutic approach, therefore no therapeutic indication is specified.

Contraindications:

  • Liquid dilution for injection D5, D6: This medicine should not be used in case of hypersensitivity to the donor animal protein.
  • Liquid dilution for injection from D8: None known.



Precautions for use and warnings:
There is no adequately documented experience with the use of this medicine in children. It should therefore only be used in children under 12 years of age after consulting a doctor.

Dosage and method of administration:
As directed by a doctor.

Duration of use:
The duration of treatment requires consultation with a doctor.

Side effects:
None known.

Contents:
10 x 1 ml.

Pharmaceutical entrepreneur and manufacturer:
WALA Heilmittel GmbH
Dorfstraße 1,
73087 Bad Boll/Eckwälden.

This package leaflet was last revised in January 2025.

Source: Information from the Wala catalog,
as of May 2025.

Active ingredient: Nervus facialis bovis Gl. Indications: Registered homeopathic medicinal product of the anthroposophical therapeutic approach, therefore without specification of a therapeutic indication.

Homeopathic medicine

Active ingredients

  • 1 ml Nervus facialis bovis glycerol extract in homeopathic dilution

Excipients

  • Water for injections
  • Sodium chloride
  • Sodium bicarbonate

Active ingredient:
Nervus facialis bovis GI
Liquid dilution for injection

Composition:
Liquid dilution for injection: 1 ml contains: Nervus facialis bovis Gl Dil. D. 1 ml (HAB, Vs. 41a)

Indications:
Registered homeopathic medicinal product of the anthroposophical therapeutic approach, therefore without specification of a therapeutic indication.

Contraindications:
Liquid dilution for injection D12: None known.

Precautions for use and warnings:
There is insufficient documented experience with the use of this medicine in children. Therefore, it should only be used in children under 12 years of age after consulting a doctor.

Dosage and method of administration:
Unless otherwise prescribed, inject 1 ml subcutaneously once a week to once a day.

Duration of use:
The duration of treatment requires consultation with the doctor.

Side effects:
None known.

View full details